The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
that was me... looking for 6p
We've got 1m unused capacity on a weekly basis for Elisa tests.. currently only have Antibody, if we can get the Antigen one signed off and tech transfer done then this should boost sales. Double the margin of the LFT as well.
Looking to expand above 1m tests per week for Antigen. - 52m a year.
Visitect CD4 - Guided figures from 1 client.
4-6m test per annum.
24m Revenue
16.8m Profit
https://www.introdent.com/shop/visitect-covid-19-igm-iga-igg-rapid-diagnostic-test/
Yes but you need antibody tests to test effectiveness of a vaccine (wish we had a T cell test as well but we don’t)
They are also good for gauging herd immunity and screening of the population.
Antibodies do provide some form immunity so as long as you have them then the rest will be useful. They also have the antigen test which they will use that capacity for.
There’s plenty of room for ODX NCYT Avct - just about waiting for the govt orders. The US is a tough cookie to crack as they prefer patriotic home based companies like Abbott’s, especially in an election year
Avacta are involved
https://www.gov.uk/government/news/new-saliva-test-for-coronavirus-piloted-in-southampton
@cautiousoptimist
https://youtu.be/09KlI9EzELE
Colin King refers to the LFT Antigen test with Mologic there
https://mologic.co.uk/mologic-covid-19-testing-at-heathrow-airport/
Is that the Antigen test the one we’re working with them on????
Feel free! Always nice when people defend their share by attacking others.. no need to be defensive, just admit that you're way behind where you thought you would be.
I'm out of the covid plays pretty much, i can't see a second wave and moved into recovery plays.
Avacta is amazing, how a company with no test is valued at near £500m ! Half a billion!
Margins on the HIV test are $4 as well.
Fantastic, and on the timeline that CK said. He is an open and honest CEO, looking forward to the rest of the timeline coming our way :)
Best scientists that have made gold standard*
Mologic developing a lateral flow antigen test, will be more Se/Sp than Avacta as they have the best Scientists that have made tests already.
However. I feel like they are missing a trick by prioritising the ELISA antigen test!